Despite falling revenues, Madison, N.J.-based Allergan's gastroenterology franchise grew by 8.2 percent in the third quarter, Market Realist reports.
Here's what you need to know.
1. The company's GI products include: Linzess, Viberzi, Asacol/Delzicol, Carafate/Sulcrate, Canasa/Salofalk and Zenpep.
2. In the third quarter, Allergan reported revenues of $431.4 million in 2016 compared to $398.6 million in 2015.
3. All Allergan GI products except Asacol/Delzicol reported positive growth.